GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Other Long-Term Liabilities

Iran Daru (XTEH:IRDR1) Other Long-Term Liabilities : IRR0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Other Long-Term Liabilities?

Iran Daru's other long-term liabilities for the quarter that ended in . 20 was IRR0.00 Mil.


Iran Daru Other Long-Term Liabilities Historical Data

The historical data trend for Iran Daru's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Other Long-Term Liabilities Chart

Iran Daru Annual Data
Trend
Other Long-Term Liabilities

Iran Daru Semi-Annual Data
Other Long-Term Liabilities

Iran Daru Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Iran Daru Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Iran Daru's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines